Related Experiment Video
Updated: Mar 14, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and
Francesca Romana Spinelli1, Arbi Pecani2, Fabrizio Conti2
1Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy francescaromana.spinelli@uniroma1.it.
Insights
Rheumatoid arthritis (RA) patients face high mortality from heart disease due to accelerated atherosclerosis. Immune responses to citrullinated and carbamylated proteins link RA and cardiovascular disease pathogenesis.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is linked to accelerated atherosclerosis and increased cardiovascular disease (CVD) risk.
- Inflammation and immune responses are implicated in both RA pathogenesis and atherosclerosis.
- The immune response to citrullinated peptides is key in RA diagnosis, but its role in atherosclerosis is less understood.
Purpose of the Study:
- To review the role of citrullination and carbamylation in the pathogenesis of RA and atherosclerosis.
- To explore the similarities between RA and atherosclerosis regarding immune responses to post-translationally modified proteins.
- To highlight potential links between immune responses to modified proteins and CVD in RA patients.
Main Methods:
- Literature review focusing on post-translational protein modifications (citrullination, carbamylation).
- Analysis of studies investigating immune responses to citrullinated peptides and carbamylated proteins in RA and CVD.
- Synthesis of evidence connecting these modifications to the pathogenesis of both diseases.
Main Results:
- Antibodies to citrullinated peptides are diagnostic for RA and may influence atherosclerosis.
- Antibodies to carbamylated proteins can precede RA onset and are found in cardiovascular disease.
- Carbamylation of lipoproteins is observed in patients with cardiovascular disease.
Conclusions:
- Citrullination and carbamylation are post-translational modifications involved in both RA and atherosclerosis.
- Shared immune responses to these modified proteins may explain the increased cardiovascular risk in RA patients.
- Further research into immune responses to modified proteins could improve understanding and management of CVD in RA.
Abstract:
Coronary heart disease is the main cause of mortality in patients with rheumatoid arthritis (RA), a disease known to be associated with accelerated atherosclerosis. The role of inflammation and immunity in atherosclerotic process offers possible explanations for the increased cardiovascular risk in patients with RA. The immune response to citrullinated peptides has been extensively studied in RA; antibodies directed to citrullinated peptides are now a cornerstone for RA diagnosis. However, few studies have investigated the response to citrullinated peptides and the development of atherosclerotic plaque. Antibodies to carbamylated proteins can be detected before the clinical onset of RA, suggesting a potential predictive role for these antibodies; on the other hand, carbamylation of lipoproteins has been described in patients with cardiovascular disease. This review examines the role of citrullination and carbamylation, two post-translational protein modifications that appear to be involved in the pathogenesis of both RA and atherosclerosis, expanding the similarities between these two diseases. Further investigation on the role of the immune response to modified proteins may contribute to a better comprehension of cardiovascular disease in patients with RA.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Atherosclerosis I: Introduction
Inflammation
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

